Miriam Rubio‐de Santos
Miriam Rubio‐de Santos publishes mostly in Endocrinology, Diabetes and Metabolism, Surgery and Pharmacology, on topics such as Diabetes Treatment and Management, Diabetes Management and Research and Hyperglycemia and glycemic control in critically ill and hospitalized patients.
- World rank
- #5,422,580 of 7,710,434 ranked researchers
- Rank in Spain
- #127,610 of 204,306
- Works
- 22
- Citations
- 57
- Citations per work
- 2.6
What does Miriam Rubio‐de Santos research?
Miriam Rubio‐de Santos's work is mostly in Medicine (74%), Biochemistry, Genetics and Molecular Biology (8%), Health Professions (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1777.4%
- Medicine1674.2%
- Health Professions13.2%
- Everything else314.6%
- Life Sciences28.0%
- 1Endocrinology, Diabetes and Metabolism63% of their works
- 2Surgery6% of their works
- 3Pharmacology5% of their works
- 4Genetics5% of their works
- 5General Health Professions3% of their works
- 6Molecular Biology3% of their works
Research topics
- Diabetes Treatment and Management
- Diabetes Management and Research
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Diabetes Management and Education
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes and associated disorders
- Pharmacology and Obesity Treatment
- Bariatric Surgery and Outcomes
Which keywords describe Miriam Rubio‐de Santos's research?
The keywords of their largest research topics: Glycemic Control, Insulin Therapy, Diabetes, Type 2 Diabetes, Cardiovascular Disease, Type 1 Diabetes, Cardiovascular Outcomes and Glucose Control.
- Metabolic Surgery
- Bariatric Surgery
- Anti-Obesity Drugs
- Insulin Resistance
- Depression
- Hyperglycemia
- Lifestyle Intervention
- Hypoglycemia
- Glucose Control
- Type 1 Diabetes
- Type 2 Diabetes
- Insulin Therapy
- Glycemic Control
- Diabetes
- Cardiovascular Disease
- Cardiovascular Outcomes
- Continuous Glucose Monitoring
- Obesity
- Critical Care
- Weight Loss
- Self-Management
- Metabolic Syndrome
- Autoimmunity
- Genetics
- Pharmacotherapy
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 25 words, with their numbers
- Glycemic Control354 topics
- Insulin Therapy303 topics
- Diabetes234 topics
- Type 2 Diabetes162 topics
- Cardiovascular Disease152 topics
- Type 1 Diabetes142 topics
- Cardiovascular Outcomes131 topic
- Glucose Control131 topic
- Continuous Glucose Monitoring111 topic
- Hypoglycemia111 topic
- Obesity103 topics
- Lifestyle Intervention72 topics
- Critical Care61 topic
- Hyperglycemia61 topic
- Weight Loss62 topics
- Depression51 topic
- Self-Management51 topic
- Insulin Resistance41 topic
- Metabolic Syndrome41 topic
- Anti-Obesity Drugs31 topic
- Autoimmunity31 topic
- Bariatric Surgery31 topic
- Genetics31 topic
- Metabolic Surgery31 topic
- Pharmacotherapy31 topic
Where does Miriam Rubio‐de Santos work?
Miriam Rubio‐de Santos's main affiliation in the publication record is Eli Lilly (Spain), Spain.
How many publications and citations does Miriam Rubio‐de Santos have?
OpenAlex counts 22 works and 57 citations for Miriam Rubio‐de Santos, an h-index of 4, ranking #5,422,580 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Miriam Rubio‐de Santos. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.